Wearable Blood Pressure Monitor Hilo Tracks 30+ Daily Readings to Cut Cardiac Risk
Swiss healthtech Hilo launches continuous blood pressure monitoring in the US, shifting cardiovascular care from snapshots to daily trend tracking.
Summary
Hilo, formerly Aktiia, has launched a wearable blood pressure system in the US that generates 30–35 readings per day using a wrist optical sensor and periodic cuff calibration. Unlike traditional cuff readings taken a few times a year, Hilo Core pairs blood pressure data with sleep, heart rate, and step count to reveal how daily habits affect cardiovascular health over time. Observational data from over 30,000 European users suggests highly engaged users saw up to fivefold greater reductions in systolic blood pressure over six months compared to low-engagement users. The platform reflects a broader shift in digital health — from episodic clinical snapshots toward continuous, personalized prevention — mirroring the impact continuous glucose monitors have had on metabolic health management.
Detailed Summary
Blood pressure remains one of the most powerful yet most neglected predictors of long-term health. Despite being a key driver of cardiovascular disease, stroke, and cognitive decline, most people only have it measured a handful of times per year — rarely enough to detect dangerous patterns or gauge the effect of lifestyle changes. Hilo, the Swiss healthtech company formerly known as Aktiia, is attempting to close that gap with the US launch of Hilo Core, a wearable system designed to make continuous blood pressure monitoring a daily habit.
The device works by reading photoplethysmographic (PPG) signals from the wrist, supplemented by periodic calibration with an FDA-cleared cuff. This approach generates roughly 30 to 35 blood pressure readings per day without repeated cuff inflation. Data is combined with sleep quality, heart rate, and physical activity metrics via a companion app, giving users and clinicians a longitudinal view of cardiovascular function as it unfolds in real life.
The company points to observational data from over 30,000 European users showing that highly engaged users experienced up to fivefold greater reductions in systolic blood pressure over six months compared to less engaged peers. While causality cannot be confirmed from observational data alone, the finding suggests that visibility and engagement together may drive meaningful behavior change — the same feedback loop that made continuous glucose monitoring transformative for metabolic health.
For longevity-focused individuals, the practical implication is significant. Hypertension is a silent risk factor — symptom-free for years while vascular damage accumulates. Catching unfavorable trends early, tracking how exercise, sleep, or dietary changes affect readings, and improving medication adherence are all enhanced by richer data.
Caveats remain. Observational engagement data is subject to selection bias. Optical wrist-based blood pressure measurement, while improving, is not yet on par with clinical-grade brachial cuff accuracy. Independent peer-reviewed trials validating the full Hilo Core system in diverse populations would strengthen confidence in its clinical utility.
Key Findings
- Hilo Core generates 30–35 blood pressure readings daily, replacing rare clinical snapshots with continuous tracking.
- Highly engaged users showed up to fivefold greater systolic blood pressure reductions over six months in observational data.
- The system combines wrist optical sensing with periodic FDA-cleared cuff calibration to maintain accuracy.
- Blood pressure trends paired with sleep, steps, and heart rate data reveal how daily behaviors drive cardiovascular risk.
- Continuous monitoring mirrors the preventive impact of CGM, shifting care from episodic to proactive.
Methodology
This is a news report and product launch announcement from Longevity.Technology, not a peer-reviewed study. Evidence cited includes eight internal clinical studies and observational data from 30,000+ European users; independent validation has not been detailed. The article presents a favorable editorial perspective on continuous monitoring as a longevity tool.
Study Limitations
Observational engagement data cannot establish causality and is likely subject to healthy user bias. Wrist-based optical blood pressure measurement has known accuracy limitations compared to validated brachial cuff devices. Independent peer-reviewed trials of the Hilo Core system specifically have not been cited in this article.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: